INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 194 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,109,000 | +60.0% | 48,062 | +71.2% | 0.00% | 0.0% |
| Q4 2020 | $693,000 | -7.0% | 28,070 | +56.2% | 0.00% | 0.0% |
| Q3 2020 | $745,000 | -21.7% | 17,970 | -9.5% | 0.00% | -50.0% |
| Q2 2020 | $952,000 | +53.5% | 19,863 | +101.8% | 0.00% | 0.0% |
| Q1 2020 | $620,000 | +21.1% | 9,842 | +138.4% | 0.00% | +100.0% |
| Q4 2019 | $512,000 | -83.5% | 4,128 | -89.4% | 0.00% | -83.3% |
| Q2 2019 | $3,105,000 | -8.2% | 39,024 | +29.1% | 0.01% | -14.3% |
| Q1 2019 | $3,381,000 | +49.6% | 30,224 | +34.8% | 0.01% | +40.0% |
| Q4 2018 | $2,260,000 | +941.5% | 22,424 | +2391.6% | 0.01% | +400.0% |
| Q2 2015 | $217,000 | -81.2% | 900 | -78.0% | 0.00% | -75.0% |
| Q1 2015 | $1,156,000 | – | 4,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |